Collegium Pharmaceutical Inc — Cash Flow (NASDAQ:COLL) | MetaTrader

Open full chart

Financials

Overview 声明 Statistics Dividends

Quarterly Annual

Cash from operating activities 93.94 M103.56 M124.23 M274.75 M204.98 M329.32 M 329.32 M Cash from investing activities 373.77 M1.94 M573.69 M70.81 M287.76 M63.53 M 63.53 M Cash from financing activities 286.47 M89.3 M436.72 M140.18 M60.6 M110.25 M 110.25 M Free cash flow -279.83 M101.61 M122.61 M274.29 M203.33 M327.58 M 327.58 M

新闻

Collegium Pharmaceutical (COLL) Q4 Earnings and Revenues Miss Estimates

Collegium Q4 2025 slides: ADHD drug surges despite earnings miss

Collegium PharmaceuticalQ4每股收益及营收逊于预期

Collegium Pharmaceutical earnings missed by $0.10, revenue fell short of estimates

Collegium Pharmaceutical财报前瞻:Jornay PM成关注焦点

Collegium Pharmaceutical earnings ahead: Jornay PM in focus

Rigel Pharmaceuticals (RIGL) Earnings Expected to Grow: Should You Buy?

Collegium Pharmaceutical to Report Q4 Earnings: What's in the Cards?

Madrigal (MDGL) Reports Q4 Loss, Beats Revenue Estimates

Truist Securities上调Collegium Pharmaceutical股票目标价至58美元

Truist Securities raises Collegium Pharmaceutical stock price target to $58

Collegium Pharmaceutical Stock: Buying The Projected Growth For 2026 (NASDAQ:COLL)